1
/
of
1
Elabscience
SKU:PKSH033640
Recombinant Human IFNα2b/IFNA2 Protein
Recombinant Human IFNα2b/IFNA2 Protein
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human IFNΑ2B/IFNA2 Protein, a cutting-edge biotechnological advancement in the field of protein synthesis. This meticulously engineered product is derived from the fusion of two distinct human interferon alpha subtypes, IFNΑ2B and IFNA2, resulting in a highly potent and versatile protein with a wide range of therapeutic applications.
The Recombinant Human IFNΑ2B/IFNA2 Protein is produced using state-of-the-art recombinant DNA technology, ensuring the utmost purity and consistency in its composition. This protein exhibits exceptional biological activity, effectively modulating the immune response and exerting antiviral, antiproliferative, and immunomodulatory effects.
With its remarkable therapeutic potential, the Recombinant Human IFNΑ2B/IFNA2 Protein finds utility in various medical disciplines. It serves as a vital component in the treatment of viral infections, including hepatitis B and C, as well as certain types of cancers, such as melanoma and leukemia. Furthermore, this protein demonstrates promise in the management of autoimmune disorders, such as multiple sclerosis and rheumatoid arthritis.
The Recombinant Human IFNΑ2B/IFNA2 Protein is meticulously manufactured under stringent quality control measures, ensuring its safety and efficacy. It is available in a lyophilized form, facilitating ease of storage and transportation, and can be reconstituted with sterile water prior to use.
In conclusion, the Recombinant Human IFNΑ2B/IFNA2 Protein represents a groundbreaking advancement in the realm of protein therapeutics. Its unrivaled potency, versatility, and therapeutic applications make it an indispensable tool in the hands of medical professionals, offering new avenues for the treatment of various diseases.
The Recombinant Human IFNΑ2B/IFNA2 Protein is produced using state-of-the-art recombinant DNA technology, ensuring the utmost purity and consistency in its composition. This protein exhibits exceptional biological activity, effectively modulating the immune response and exerting antiviral, antiproliferative, and immunomodulatory effects.
With its remarkable therapeutic potential, the Recombinant Human IFNΑ2B/IFNA2 Protein finds utility in various medical disciplines. It serves as a vital component in the treatment of viral infections, including hepatitis B and C, as well as certain types of cancers, such as melanoma and leukemia. Furthermore, this protein demonstrates promise in the management of autoimmune disorders, such as multiple sclerosis and rheumatoid arthritis.
The Recombinant Human IFNΑ2B/IFNA2 Protein is meticulously manufactured under stringent quality control measures, ensuring its safety and efficacy. It is available in a lyophilized form, facilitating ease of storage and transportation, and can be reconstituted with sterile water prior to use.
In conclusion, the Recombinant Human IFNΑ2B/IFNA2 Protein represents a groundbreaking advancement in the realm of protein therapeutics. Its unrivaled potency, versatility, and therapeutic applications make it an indispensable tool in the hands of medical professionals, offering new avenues for the treatment of various diseases.
Share
